Stockreport

NanoViricides files for Rare Pediatric Disease Designation for Measles Drug [Yahoo! Finance]

NanoViricides, Inc.  (NNVC) 
NASDAQ:AMEX Investor Relations: nanoviricides.com/investorinfo.html
PDF FDA's Office of Orphan Products Development for NV-387 as a treatment for measles. The RPDD application is expected to be combined with the company's previously submit [Read more]